MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Study with Confirmatory Evidence BLA Filing Strategy for CARTISTEM® in the U.S.
SEOUL, South Korea, June 4, 2026 /PRNewswire/ — MEDIPOST, a fully integrated commercial stage cell therapy biotechnology company, announced today that it has secured the FDA’s agreement to conduct a single pivotal Phase 3 study for CARTISTEM® in the U.S. This milestone marks a significant step forward in MEDIPOST’s mission to bring its first-in-class knee […]




![[Global Capital Opportunities] Global Investor Institute Officially Launched — Aims to Establish Hong Kong as the World Investors Hub [Global Capital Opportunities] Global Investor Institute Officially Launched — Aims to Establish Hong Kong as the World Investors Hub](https://i2.wp.com/mma.prnasia.com/media2/2993275/Picture1.jpg?p=medium600&w=800&resize=800,450&ssl=1)


